tiprankstipranks
Dexcom (CH:DC4)
NASDAQ:DC4
Switzerland Market
DC4
Dexcom
RESEARCH TOOLSreports

Dexcom (DC4) Ratios

0 Followers

Dexcom Ratios

CH:DC4's free cash flow for Q1 2026 was $0.63. For the 2026 fiscal year, CH:DC4's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.95 1.88 1.47 2.84 1.99
Quick Ratio
 1.64 1.59 1.28 2.48 1.83
Cash Ratio
 0.50 0.43 0.21 0.36 0.35
Solvency Ratio
 0.32 0.30 0.18 0.17 0.15
Operating Cash Flow Ratio
 0.80 0.67 0.34 0.48 0.36
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.82 0.00 0.87
Net Current Asset Value
$ 655.30M$ 439.40M$ -80.50M$ 230.00M$ 408.90M
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.22 0.40 0.41 0.40
Debt-to-Equity Ratio
 0.47 0.51 1.23 1.25 1.01
Debt-to-Capital Ratio
 0.32 0.34 0.55 0.56 0.50
Long-Term Debt-to-Capital Ratio
 0.30 0.31 0.37 0.54 0.36
Financial Leverage Ratio
 2.24 2.31 3.08 3.03 2.53
Debt Service Coverage Ratio
 74.93 49.81 0.66 36.84 0.65
Interest Coverage Ratio
 75.99 49.83 31.58 29.44 21.03
Debt to Market Cap
 0.04 0.05 0.08 0.05 0.04
Interest Debt Per Share
 3.63 3.61 6.44 6.77 5.56
Net Debt to EBITDA
 0.21 0.41 2.10 2.21 2.66
Profitability Margins
Gross Profit Margin
61.84%60.01%60.46%63.19%64.72%
EBIT Margin
21.45%19.56%18.05%20.17%14.07%
EBITDA Margin
26.82%24.96%23.45%25.31%19.43%
Operating Profit Margin
21.45%19.56%14.88%16.50%13.44%
Pretax Profit Margin
24.98%23.35%17.58%19.61%13.43%
Net Profit Margin
19.31%17.94%14.29%14.95%11.73%
Continuous Operations Profit Margin
19.31%17.94%14.29%14.95%11.73%
Net Income Per EBT
77.30%76.84%81.27%76.22%87.31%
EBT Per EBIT
116.47%119.37%118.17%118.86%99.90%
Return on Assets (ROA)
14.03%13.19%8.89%8.64%6.33%
Return on Equity (ROE)
33.83%30.46%27.40%26.18%16.01%
Return on Capital Employed (ROCE)
23.44%21.72%16.89%12.69%11.01%
Return on Invested Capital (ROIC)
18.03%16.61%10.20%9.63%7.86%
Return on Tangible Assets
14.21%13.39%9.06%8.87%6.57%
Earnings Yield
3.28%3.23%1.83%1.13%0.77%
Efficiency Ratios
Receivables Turnover
 4.36 3.61 3.90 3.67 3.87
Payables Turnover
 4.66 5.41 4.62 4.82 4.32
Inventory Turnover
 2.65 2.96 2.94 2.38 3.35
Fixed Asset Turnover
 2.95 2.85 2.88 3.06 2.56
Asset Turnover
 0.73 0.74 0.62 0.58 0.54
Working Capital Turnover Ratio
 2.41 2.86 1.90 1.54 1.21
Cash Conversion Cycle
 143.14 156.75 138.70 177.03 118.81
Days of Sales Outstanding
 83.73 100.99 93.54 99.51 94.35
Days of Inventory Outstanding
 137.69 123.17 124.18 153.18 109.03
Days of Payables Outstanding
 78.27 67.41 79.03 75.66 84.58
Operating Cycle
 221.42 224.16 217.73 252.69 203.39
Cash Flow Ratios
Operating Cash Flow Per Share
 4.63 3.69 2.45 1.94 1.72
Free Cash Flow Per Share
 3.71 2.76 1.56 1.33 0.78
CapEx Per Share
 0.92 0.93 0.89 0.61 0.94
Free Cash Flow to Operating Cash Flow
 0.80 0.75 0.64 0.68 0.46
Dividend Paid and CapEx Coverage Ratio
 5.05 3.96 2.76 3.16 1.84
Capital Expenditure Coverage Ratio
 5.05 3.96 2.76 3.16 1.84
Operating Cash Flow Coverage Ratio
 1.29 1.04 0.38 0.29 0.31
Operating Cash Flow to Sales Ratio
 0.37 0.31 0.25 0.21 0.23
Free Cash Flow Yield
5.02%4.16%2.00%1.07%0.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 31.71 30.97 54.61 88.46 129.24
Price-to-Sales (P/S) Ratio
 6.14 5.56 7.80 13.22 15.15
Price-to-Book (P/B) Ratio
 9.98 9.43 14.97 23.16 20.68
Price-to-Free Cash Flow (P/FCF) Ratio
 20.68 24.04 49.89 93.57 144.72
Price-to-Operating Cash Flow Ratio
 16.55 17.98 31.80 63.99 65.86
Price-to-Earnings Growth (PEG) Ratio
 0.42 0.66 39.32 1.39 2.26
Price-to-Fair Value
 9.98 9.43 14.97 23.16 20.68
Enterprise Value Multiple
 23.08 22.66 35.37 54.46 80.66
Enterprise Value
 28.72B 26.37B 33.45B 49.93B 45.60B
EV to EBITDA
 22.22 22.66 35.37 54.46 80.66
EV to Sales
 5.96 5.66 8.29 13.78 15.67
EV to Free Cash Flow
 20.09 24.48 53.03 97.53 149.65
EV to Operating Cash Flow
 16.11 18.30 33.80 66.70 68.11
Tangible Book Value Per Share
 7.45 6.79 4.88 4.95 4.96
Shareholders’ Equity Per Share
 7.68 7.04 5.20 5.36 5.47
Tax and Other Ratios
Effective Tax Rate
 0.23 0.23 0.19 0.24 0.13
Revenue Per Share
 12.51 11.95 9.97 9.38 7.47
Net Income Per Share
 2.42 2.14 1.42 1.40 0.88
Tax Burden
 0.77 0.77 0.81 0.76 0.87
Interest Burden
 1.16 1.19 0.97 0.97 0.95
Research & Development to Revenue
 0.12 0.13 0.14 0.14 0.17
SG&A to Revenue
 0.28 0.28 0.32 0.00 0.00
Stock-Based Compensation to Revenue
 0.04 0.03 0.04 0.04 0.04
Income Quality
 1.92 1.72 1.72 1.38 1.96
Currency in USD